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This study concerns a series of 23 cases of disseminated neurodermatitis treated with
Thephorin.' The preparations employed in the treatment of these patients were a syrup,
containing 10 milligrams of Thephorin per dram, and tablets, each containing 25 milligrams.
Both of these are now available commercially. In addition, we employed a five percent
ointment of the Thephorin base in a carbowax vehicle.
This series consists of 21 patients who were treated with both local and oral medication,
and two patients who received only the ointment. The ages of the patients were from five
months to 52 years. The degree of involvement varied from that of a mild antecubital or
periorbital eruption to acutely pruritic and exudative eruptions involving most of the
fiexural areas. Of the 23 patients, nine gave a definite family history of allergic disease,
while no such history could be elicited in the remainder.
The duration of the disease varied from two weeks to 17 years. The treatment period
varied from one to seven weeks. Treatment was carried out during the severest part of the
winter and the results reported do not include any period during which spontaneous seasonal
clearing, which is so often observed, could be noted among other such patients.
The results of treatment were as follows:
Complete clearing 2
More than 75% but less than complete clearing 7
More than 50% but less than 75% clearing 8
Benefitted but less than 50% clearing 2
Not benefitted 3
Became worse (Patch tests negative) 1
In four of the 23 patients there were side effects of irritability and sleeplessness. These
patients were all infants to whom both the local and oral medication had been given. The
side effects promptly subsided when the oral drug was stopped. In these four patients the
lack of any oral medication did not seem to slow the rate of improvement. For a period of two
weeks three patients received Thephorin orally together with tars, etc., before a supply of
Thephorin ointment arrived. No benefit attributable to the Thephorin could be noted in
these patients.
The dosages employed by us were not as large as those used by Kesten and Sheard (1).
The adult dose was usually 25 milligrams three times daily and in no case was the total
daily dose carried beyond 100 milligrams. The total daily dose to infants was 15 to 20
milligrams and that to children 30 to 40 milligrams.
Simultaneously with the above patients a control series was treated. This series con-
sisted of six patients, one of which cleared completely with application only of the carbowax
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'Brand of Phenindamine, supplied by lloffmann La Roche, Inc. The syrup and tablet
forms consisted of the hydrogen tartrate salt of the Thephorin base. The phosphate salt
of the Thephorin base was used in the ointment. The formula for the Thephorin base is
2-methyl-9 phenyltetrahydro-1-pyridindene.
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vehicle, while the remaining five showed conclusive improvement in the areas treated with
the Thephorin ointment, but no improvement in those treated with the ointment base alone.
concLusIons
1. The treatment of disseminated neurodermatitis with Thephorin showed promising
results in a series of 23 cases.
2. The local administration of Thephorin in ointment form is the most effective. It is
our opinion that oral administration could be entirely omitted without materially affecting
the results of treatment. No patients were treated with oral medication alone.
3. It seems likely, in view of the consistent failure of previous antihistaminic drugs in
the treatment of disseminated neurodermatitis, that Thephorin has a mode of action which
is distinctly different from the others since it is not a significantly more powerful antihis-
taminic agent.
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